Piper Sandler raises AbbVie (NYSE:ABBV) price target from $163 to $170
Piper Sandler analyst Christopher Raymond maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $163 to $170.
Piper Sandler raises AbbVie (NYSE:ABBV) price target from $163 to $170 Read Post »